IGLON5 and supranuclear palsy, progressive, 1: Additionally, an overlap in the clinical manifestations of PSPS and anti–IgLON-5 encephalopathy and in the pathology of PSP and CTE demonstrate the necessity of combined analysis for elucidating the corresponding pathomechanisms.